Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Cellmark Q3 Revenues Slide 7 Percent

NEW YORK (GenomeWeb News) – Orchid Cellmark reported on Monday a 7 percent decline year over year in third-quarter revenues.

In its quarterly earnings report filed with the US Securities and Exchange Commission, the company, which is in the process of being acquired by Laboratory Corporation of America for $85.4 million, said that total revenues for the three months ended Sept. 30 slid to $16.1 million from $17.3 million in the comparable year-ago period.

Virtually all of its revenues come from its service business while other revenues dropped to $8,000, down from $13,000 a year ago.

The Princeton, NJ-based firm cut R&D expenses 3 percent to $335,000 from $344,000 a year ago, and decreased SG&A spending 6 percent to $4.7 million from $5 million.

Net loss for the quarter doubled to $1.3 million, or $.04 per share, from $665,000, or $.02 per share a year ago.

Today, LabCorp announced it had extended it cash tender offer for Orchid Cellmark to Nov. 30.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.